Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$13.09 - $18.77 $132,523 - $190,027
-10,124 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$12.22 - $15.79 $123,715 - $159,857
10,124 New
10,124 $141,000
Q4 2020

Feb 16, 2021

SELL
$11.65 - $22.07 $170,625 - $323,237
-14,646 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.96 - $14.12 $131,228 - $206,801
14,646 New
14,646 $163,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $30.2M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.